Trailblazing Cambridge pharmaceutical supplier, Qdem, aims to follow its stellar 2017 with an outstanding...

Leaders of the pack Trailblazing Cambridge pharmaceutical supplier, Qdem, aims to follow its stellar 2017 with an outstanding 2018, all while delivering quality and value...

Closed loop – the DNA of pharma marketing by Kieran Bourke

  When planning a marketing strategy, pharmaceutical companies should consider adopting an integrated approach to make the most of the data they collect through website...

Into the 21st century: Inicio Consulting’s modern and panoramic approach means all bases are...

Unique Inicio is a niche go-to, multi-disciplinary agency that fuses strategic and commercial acumen with creative and analytical thinking. Our focus is on enhancing operational...

That was the year that was: For Novo Nordisk humanity and being human defined...

That was the year that was: For Novo Nordisk humanity and being human defined 2017 What is Novo Nordisk and what makes it unique? At Novo Nordisk,...

Pharma marvels: PharmaMar achieves innovation, sustainability and ambition in oncology.

  PharmaMar, a multinational biopharmaceutical company based in Spain and founded in 1986, is advancing the treatment of cancer through the discovery, development and marketing...

Altogether now: Ensuring treatment access for patients at risk of fragility fractures

Worldwide, 1 in 3 women and 1 in 5 men, over the age of 50 will experience a fragility fracture in their lifetime. A...

Andrew Wilkinson & Samantha Prindiville on QuintilesIMS’s unique culture & forging a career in...

QuintilesIMS duo Andrew Wilkinson and Samantha Prindiville on the company’s unique culture and forging a career in medical sales. Describe the QuintilesIMS culture. Integrity is at...
new research into the relationship between sleep medication and dementia

Return to life: Otsuka and Lundbeck want people with schizophrenia to achieve their aspirations.

This article has been sponsored by Otsuka and Lundbeck and has had input from Otsuka and Lundbeck into the editorial content. Otsuka and Lundbeck’s ‘Head...

Mental health treatment experts Lundbeck on the challenges facing industry, healthcare and wider society.

Depression is the leading cause of disability worldwide and a major contributor to the overall global burden of disease. In the UK, mental health...

Pf Awards 2017 winner profile: Shaun Hopkins & Tracey Murphy

Coloplast’s, NHS Partnership Manager, Shaun Hopkins, and Registered Nurse, Tracey Murphy – Winners of the Account Project Award. What do you do at Coloplast? SH:...

Latest articles

robot holding chess piece: Cyber threats in healthcare

Cyber threats in healthcare: What are the risks?

FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
Positive results for long acting injectable HIV treatment regimen

Positive phase III study results for injectable HIV-treatment regimen

ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
Gedeon Richter's biosimilar for osteoporosis available on NHS

Gedeon Richter’s biosimilar for osteoporosis available on NHS

Gedeon Richter has announced that its biosimilar for osteoporosis, Terrosa® (teriparatide), is available on the NHS for the treatment of osteoporosis in postmenopausal women...

Popular articles

Roche's Hemlibra® available on NHS

NHS England makes Roche’s Hemlibra® available on NHS

NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Positive results for long acting injectable HIV treatment regimen

Positive phase III study results for injectable HIV-treatment regimen

ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
Gedeon Richter's biosimilar for osteoporosis available on NHS

Gedeon Richter’s biosimilar for osteoporosis available on NHS

Gedeon Richter has announced that its biosimilar for osteoporosis, Terrosa® (teriparatide), is available on the NHS for the treatment of osteoporosis in postmenopausal women...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Building blocks: Building trust with sales representatives

Building trust in health with sales representatives

Paul Terry explores how the sales representative is best placed to build trust with the health sector, and how industry needs to adapt to...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription